YTHDF2 inhibits inflammasome-mediated tumor vascularization and malignancy by degradation of m6A-containing serpin family E member 2 (SERPINE2) and interleukin-11 (IL-11) mRNA (25, 26). Here, YTHDF2 is linked to neoplasm.